The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
Dialogue, which has, until now, solely focused on providing a virtual healthcare solution, appears to be expanding into new verticals with the new offering.
With COVID-19, it has never been more important to understand how Canadian firms innovate. The Conference Board of Canada is publishing an in-depth study on how innovation translates into growth.
Canadian tech firms and ecosystem partners are invited to join the survey. You will be first to receive the full report.
The deal with Hillhouse, an early backer in JD.com and an aggressive pursuer of opportunities in healthcare, is expected to occur in Q3 this year.
Before it can proceed to human clinical trials, the facility needs to complete more studies using higher-grade materials than what they needed for their early animal studies. But waiting for busy manufacturers to provide them is holding up the process.
Some startups grapple with USPS delays in medication delivery (MED CITY NEWS)
Some healthcare startups that offer at-home prescription deliveries and test kits have experienced delays with the USPS. They shared how they’re navigating the changes.
Including the Series B+ funding round, Exo has raised nearly $100 million, according to the company.
Well Health Technologies, a publicly-traded healthtech company, has acquired the services division of Toronto-based cybersecurity startup Cycura.
The platform recently launched in California, and is eyeing more states down the line.
Uber launches prescription delivery service in Seattle, Dallas (NEW YORK POST)
Uber has started delivering prescriptions to help people avoid trips to the pharmacy during the coronavirus pandemic.
Founded in 2011, Castor is a cloud-based clinical data platform that simplifies the clinical trial process, from recruitment to analysis, for researchers globally.
It’s not new that gender inequality is prevalent in venture capital. In 2018, the CFA Institute reported that only 2.2 percent of venture capital spending went to female founders.
Subscribe to The Healthtech Times
Don’t forget to subscribe to The Healthtech Times using the form below to make sure it hits your email inbox every week!